Company news
Personalis, Inc. news in 2024
Personalis, Inc.'s news releases, calls and decks from 2024, newest first.
Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
December 18, 2024
Personalis and Tempus Expand Collaboration to Biopharma
December 15, 2024
Personalis to Participate at Upcoming Investor Conferences
November 19, 2024
Personalis Reports Third Quarter 2024 Financial Results
November 5, 2024
Personalis to Present at the Stifel 2024 Healthcare Conference
November 4, 2024
Personalis to Announce Third Quarter 2024 Financial Results
October 22, 2024
ESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD Test
September 15, 2024
Personalis and Tempus Announce Expanded Collaboration
August 15, 2024
Personalis Reports Second Quarter 2024 Financial Results
August 6, 2024
Personalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
July 30, 2024
Personalis to Announce Second Quarter 2024 Financial Results
July 23, 2024
Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to Testing
July 10, 2024
Personalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution Conference
June 17, 2024
Personalis Provides Dial-in and Updated Date for ASCO Highlights Conference Call
June 12, 2024
ASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy Monitoring
June 3, 2024
Personalis Announces Start of Cancer MRD Testing Commercialization Collaboration with Tempus
May 30, 2024
Personalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024
May 21, 2024
Personalis Reports First Quarter 2024 Financial Results
May 7, 2024
Personalis to Announce First Quarter 2024 Financial Results
April 23, 2024
Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference
March 27, 2024
Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting
March 27, 2024
Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring
March 25, 2024
Personalis Reports Fourth Quarter and Full Year 2023 Financial Results
February 27, 2024
Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results
February 13, 2024
Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology
January 29, 2024
Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay
January 15, 2024
Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance
January 4, 2024